Visit COVID-19 resources

[Skip to Content]

Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab – (Eye Journal AOP)

9 October 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login